Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed HIV-1 infection
- People who are 25 years of age or older
- People who are willing and able to sign a written consent form to participate
Who may not be able to join:
- People who are pregnant or planning to become pregnant within 90 days of enrolling in the trial
- People who have already had a cervical cancer screening in the past year (within the last 365 days)
- People who currently have an active sexually transmitted infection (STI), although women who have been treated for an STI may still be considered
- People who have had their cervix surgically removed
- People who have a history of cervical cancer
- People who have previously received a vaccine against HPV (human papillomavirus)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carla Chibwesha, MD, MSc, Division of Global Women's Health Department of Obstetrics and Gynecology, UNC Chapel Hill, NC
Phone: 919-843-2541
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical performance of hrHPV testing in the three sample types for the detection of CIN2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.